FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Dermira's Free Cash Flow for the
three
months ended in Sep. 2019 was $-6.17 Mil. Dermira's Revenue for the
three
months ended in Sep. 2019 was $11.53 Mil. Therefore, Dermira's FCF Margin % for the quarter that ended in Sep. 2019 was -53.49%.
The historical rank and industry rank for Dermira's FCF Margin % or its related term are showing as below:
DERM'
s FCF Margin % Range Over the Past 10 Years
Min: -296 Med: 0 Max: 0
Current: -296
DERM's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -148.935
vs DERM: -296.00
Dermira FCF Margin % Historical Data
The historical data trend for Dermira's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Dermira's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dermira's FCF Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Dermira's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Dermira's FCF Margin % falls into.
Dermira FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Dermira's FCF Margin for the fiscal year that ended in Dec. 2018 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dermira FCF Margin % Related Terms
Thank you for viewing the detailed overview of Dermira's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Dermira Inc is a biopharmaceutical company focuses on the development and commercialization of medical dermatology products to dermatologists and their patients primarily in the United States.The company's late-stage product candidates include Cimzia, an injectable biologic tumor necrosis factor-alpha inhibitor to treat various inflammatory diseases, as well as to treat patients with moderate-to-severe chronic plaque psoriasis; Glycopyrronium tosylate, a small-molecule anticholinergic product that is in Phase III clinical trial for the treatment of primary axillary hyperhidrosis or excessive underarm sweating; and Olumacostat glasaretil, a small-molecule sebum inhibitor, which is in Phase III clinical trial to treat acne vulgaris or acne.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DERM has been successfully added to your 